SCHEMBL8095018

SCHEMBL8095018

CCC(C)S(=O)(=O)NC(=O)Nc1ccc(Br)cc1

nearest known ligand 0.60

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.60
FPR2 P25090 10/20 0.57
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
LMNA P02545 1/20 0.49
POLB P06746 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
CA12 O43570 1/20 0.48
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
CA9 Q16790 1/20 0.48
NPC1 O15118 1/20 0.46
MAOA P21397 1/20 0.46
MAOB P27338 1/20 0.46
FPR1 P21462 1/20 0.46
CNR1 P21554 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8094980 0.85 TP53 (0.52) RAB9AMEN1KMT2ALMNASMN1; SMN2
SCHEMBL8089925 0.85 ALDH1A1 (0.50) RAB9AFPR2MEN1KMT2ALMNA
SCHEMBL21104548 0.85 ACP1 (0.56) RAB9AMEN1KMT2ALMNASMN1; SMN2
SCHEMBL8083324 0.84 FPR2 (0.56) RAB9AFPR2MEN1KMT2ALMNA
SCHEMBL8095025 0.83 FPR2 (0.55) RAB9AFPR2MEN1KMT2ALMNA
SCHEMBL8095034 0.79 EPHX1 (0.55) RAB9AMEN1KMT2ALMNAPOLB
SCHEMBL9339228 0.76 FAAH (0.41) RAB9AFPR2MEN1KMT2APOLB
SCHEMBL9341223 0.73 NPC1 (0.48) RAB9AMEN1KMT2ALMNAPOLB
SCHEMBL22175221 0.72 FPR2 (1.00) RAB9AFPR2MEN1KMT2ALMNA
SCHEMBL16020523 0.72 FPR2 (1.00) RAB9AFPR2MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6147115-A SULFONYLUREIDO-4-HALOBENZENE DERIVATIVES; ANTICARCINOGENIC AGENTS ELI LILLY AND COMPANY (US) 2000-11-14 US disclosed
EP-0467621-B1 N-phenyl-N'-alkylsulfonylureas, process for their preparation and antitumor compositions containing them LILLY CO ELI (US) 1994-06-15 EP disclosed
US-5216026-A Administering to the mammal N-1-butanesulfonamide derivatives and salts ELI LILLY AND COMPANY (US) 1993-06-01 US disclosed
EP-0467621-A1 N-phenyl-N'-alkylsulfonylureas, process for their preparation and antitumor compositions containing them ELI LILLY AND COMPANY (US) 1992-01-22 EP disclosed